An abnormal fluctuation in stock trading was announced by Xiangyu Medical. Recently, the capital market is paying a lot of attention to concepts such as human brain engineering and brain-computer interface, and stock prices in related sectors have risen significantly. Currently, the company mainly focuses on non-invasive brain-computer interface technology, covering the full rehabilitation scenario layout of occupational therapy, exercise therapy, cognitive speech, swallowing, etc., which is different from the current international intrusive brain-computer interface technology route. The company's investment in brain-computer interfaces has now formed a certain layout in terms of technology, products, channel markets, etc., but tendering and sales are lagging behind. By the end of 2025, related products had not yet achieved large-scale sales, and their revenue share was relatively small.

An abnormal fluctuation in stock trading was announced by Xiangyu Medical. Recently, the capital market is paying a lot of attention to concepts such as human brain engineering and brain-computer interface, and stock prices in related sectors have risen significantly. Currently, the company mainly focuses on non-invasive brain-computer interface technology, covering the full rehabilitation scenario layout of occupational therapy, exercise therapy, cognitive speech, swallowing, etc., which is different from the current international intrusive brain-computer interface technology route. The company's investment in brain-computer interfaces has now formed a certain layout in terms of technology, products, channel markets, etc., but tendering and sales are lagging behind. By the end of 2025, related products had not yet achieved large-scale sales, and their revenue share was relatively small.